More on RPRX
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $45.68 |
|
|||
| Open | $45.59 | ||||
| 52 Wk High | $3.48 | ||||
| 52 Wk Low | $0.80 | ||||
| Day High | $45.68 | ||||
| Day Low | $44.94 | ||||
| P/E | N/A | ||||
| EPS | $-1.54 | ||||
| Volume | 2,701,069 | ||||
- Form 4 Royalty Pharma plc For: Mar 02 Filed by: Coyne Terrance P.
- Form 144 Royalty Pharma plc Filed by: Lloyd George W.
- Form 144 Royalty Pharma plc Filed by: Coyne Terrance P.
- Royalty Pharma names Kenneth Sun as head of Asia operations
- Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform
- Royalty Pharma names Kenneth Sun as head of Asia operations
- Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform
- Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing
- Zymeworks secures $250 million in royalty-backed financing from Royalty Pharma
- Zymeworks and Royalty Pharma Enter into $250 Million Royalty-Backed Note Financing
Entities mentioned with RPRX
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- FDA | View Related Stories »
- Dividend | View Related Stories »
- 13G | View Related Stories »
- Morgan Stanley | View Related Stories »
- JPMorgan | View Related Stories »
- Cowen & Co | View Related Stories »
- Show More...
